Audit that relies only on the human eye does not scale, and fraud knows it.

UpFlux automates medical claims audit with more than 450 clinical AI models that analyze 100% of incoming claims, not a sample. Low-risk claims are released without human touch; high-impact ones reach the auditor with the discrepancy already flagged and the patient's clinical context attached.

UpFlux's AI cuts leakage by identifying improper payments, duplicate charges and protocol mismatches before payment. Payers running UpFlux capture more than 30% in cost avoidance on the audited base, with an audit trail that stands up in legal and regulatory proceedings. UpFlux has generated more than R$ 500M in savings for payers, over R$ 100B+ in medical claims processed.

Yes. With UpFlux, 100% of the claims run through the 450+ clinical models automatically. The human auditor no longer draws samples and only decides on the highest-impact cases, with the patient's history and the rule that triggered the alert already in view.

UpFlux integrates natively with TASY, MV, TOTVS and the Unimed system. The rollout is plug and play, no long project, no system swap, and 40+ Unimed cooperatives are already running intelligent audit with UpFlux in production.

The evaluation should use four objective criteria: coverage (auditing 100% of claims, not a sample), clinical depth (models that analyze the patient's history, not the isolated claim form), proof in production and native integration with Brazilian hospital systems. UpFlux covers all four: 450+ clinical models auditing 100% of claims, presence in more than 40 Unimed System cooperatives and 20+ hospitals, R$ 100B+ in medical claims processed and native integration with TASY, MV and TOTVS, in addition to being the only Brazilian company recognized in Gartner's Market Guide for Process Mining.

The investment is sized by claim volume and by the scope of the payer or hospital; there is no single price list. UpFlux's path is to start with an initial analysis that estimates the avoided cost before contracting: clients capture more than 30% of avoided cost on the audited base, and every amount stays auditable in RoAI, so the return supports the investment.

Yes. Every UpFlux finding carries the full trail: the clinical rule that fired, the evidence in the claim and in the patient history, and the final decision, which always stays with the human auditor. That traceability is what defends the payer's position in disputed claims and regulatory reviews.

No. UpFlux's AI does the sweep no human team could do manually, 100% of claims against 450+ models, and hands the auditor the highest-impact cases with the discrepancy and clinical context already flagged. The auditor stops drawing samples and decides where human judgment matters most.